L3VLUP
ProSign in

CNMD · LLY in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

CNMDLLY
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • CNMD
  • LLY
0204060202120222023202420252026
Holders and value by quarter
QuarterCNMDLLY
Q3 202010 holders, $208m33 holders, $14.1bn
Q4 20206 holders, $180m29 holders, $17.3bn
Q1 20217 holders, $171m24 holders, $23.0bn
Q2 20214 holders, $185m24 holders, $27.8bn
Q3 20216 holders, $173m31 holders, $29.9bn
Q4 20213 holders, $179m31 holders, $34.7bn
Q1 20226 holders, $233m24 holders, $35.3bn
Q2 20225 holders, $180m33 holders, $42.7bn
Q3 20225 holders, $153m31 holders, $43.4bn
Q4 20225 holders, $209m31 holders, $46.6bn
Q1 20235 holders, $268m33 holders, $44.3bn
Q2 20233 holders, $345m37 holders, $59.6bn
Q3 20237 holders, $301m44 holders, $67.6bn
Q4 20234 holders, $318m45 holders, $73.6bn
Q1 20246 holders, $133m41 holders, $95.3bn
Q2 20244 holders, $134m43 holders, $110bn
Q3 20243 holders, $119m45 holders, $107bn
Q4 20244 holders, $115m46 holders, $93.9bn
Q1 20253 holders, $109m42 holders, $98.4bn
Q2 20254 holders, $95m43 holders, $93.2bn
Q3 20255 holders, $58m39 holders, $86.7bn
Q4 20254 holders, $43m41 holders, $123bn
Q1 20262 holders, $34m39 holders, $106bn
Q2 20261 holders, $27m44 holders, $132bn
CNMD

Conmed Corp

Holders
5
Reported value
$58m
Buyers
3
Sellers
1

Breadth +2 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUPSurgical, medical and electromedical devices
LLY

Eli Lilly & Co

Holders
39
Reported value
$86.7bn
Buyers
22
Sellers
22

Breadth 0 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q3 2025

Among the 41 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only CNMD (2)

Moore Capital Management LP, PDT Partners LLC

Only LLY (36)

Acadian Asset Management LLC, AllianceBernstein LP, AQR Capital Management LLC, Arrowstreet Capital LP, Artisan Partners LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital World Investors, Caxton Associates LLP, Citadel Advisors LLC, D. E. Shaw & Co., Dodge & Cox, Eisler Capital Management Ltd, Fidelity (FMR LLC), Freestone Grove Partners LP, Harris Associates LP, Holocene Advisors LP, Hudson Bay Capital Management LP, Invesco Ltd, Jane Street Group LLC, Janus Henderson Group Ltd, Man Group PLC, Marshall Wace LLP, Millennium Management LLC, and 11 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →